Jang Bum-Sup, Eom Keun-Yong, Cho Hwan Seong, Song Changhoon, Kim In Ah, Kim Jae-Sung
Department of Radiation Oncology, Seoul National University Hospital, Seoul, Korea.
Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam, Korea.
Radiat Oncol J. 2019 Mar;37(1):51-59. doi: 10.3857/roj.2018.00507. Epub 2019 Mar 31.
We evaluated failure pattern and treatment outcomes of observational approach on regional lymph node (LN) in cutaneous melanoma of extremities and sought to find clinico-pathologic factors related to LN metastases.
We retrospectively reviewed 73 patients with cutaneous melanoma of extremities between 2005 and 2016. If preoperative 18-F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) findings were non-specific for regional LNs, surgical resection of primary tumors with adequate margins was performed without sentinel lymph node biopsy (SLNB) and/or complete lymph node dissection (CLND), irrespective of tumor thickness or size. In patients with suspicious or positive findings on PET/CT or CT, SLNB followed by CLND or CLND was performed at the discretion of the surgeon. We defined LN dissection (LND) as SLNB and/or CLND.
With a median follow-up of 38 months (range, 6 to 138 months), the dominant pattern of failure was regional failure (17 of total 23 events, 74%) in the observation group (n = 56). Pathologic LN metastases were significant factor for poor regional failure-free survival (hazard ration [HR] = 3.21; 95% confidence interval [CI], 1.03-10.33; p = 0.044) and overall survival (HR = 3.62; 95% CI, 1.02-12.94; p = 0.047) in multivariate analysis. In subgroup analysis for cN0 patients according to the preoperative PET/CT findings, LND group showed the better trend of LRFFS (log rank test, p = 0.192) and RFFS (p = 0.310), although which is not statistically significant.
Observational approach on regional LNs on the basis of the PET/CT in patients with cutaneous melanoma of extremities showed the dominant regional failure pattern compared to upfront LND approach. To reveal regional lymph node status, SLND for cN0 patients may of importance in managing cutaneous melanoma patients.
我们评估了对肢体皮肤黑色素瘤区域淋巴结(LN)采用观察性方法的失败模式和治疗结果,并试图找出与LN转移相关的临床病理因素。
我们回顾性分析了2005年至2016年间73例肢体皮肤黑色素瘤患者。如果术前18F-氟脱氧葡萄糖(FDG)-正电子发射断层扫描/计算机断层扫描(PET/CT)对区域LN的检查结果不具有特异性,则在不进行前哨淋巴结活检(SLNB)和/或完整淋巴结清扫(CLND)的情况下,对原发性肿瘤进行具有足够切缘的手术切除,无论肿瘤厚度或大小如何。对于PET/CT或CT检查结果可疑或阳性的患者,根据外科医生的判断进行SLNB,随后进行CLND或直接进行CLND。我们将淋巴结清扫(LND)定义为SLNB和/或CLND。
中位随访时间为38个月(范围6至138个月),观察组(n = 56)中主要的失败模式是区域失败(23例事件中的17例,74%)。在多因素分析中,病理LN转移是区域无失败生存不良(风险比[HR]=3.21;95%置信区间[CI],1.03 - 10.33;p = 0.044)和总生存不良(HR = 3.62;95%CI,1.02 - 12.94;p = 0.047)的重要因素。在根据术前PET/CT检查结果对cN0患者进行的亚组分析中,LND组显示出更好的局部无复发生存(LRFFS)趋势(对数秩检验,p = 0.192)和区域无复发生存(RFFS)趋势(p = 0.310),尽管差异无统计学意义。
与直接进行LND的方法相比,基于PET/CT对肢体皮肤黑色素瘤患者的区域LN采用观察性方法显示出主要的区域失败模式。对于cN0患者,进行前哨淋巴结清扫以明确区域淋巴结状态对于管理皮肤黑色素瘤患者可能具有重要意义。